BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1491643)

  • 21. Effects on casual and 24-h ambulatory blood pressure of slow-release nicardipine and chlorthalidone in arterial essential hypertension: double-blind, crossover study.
    Celentano A; Galderisi M; Tammaro P; Mureddu GF; Garofalo M; de Divitiis O
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):190-6. PubMed ID: 2365538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril versus slow release nifedipine in patients with essential hypertension: a multicentre study.
    Predel HG; Kramer HJ
    J Hum Hypertens; 1994 Oct; 8(10):777-80. PubMed ID: 7837215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins.
    Karlberg BE; Lins LE; Rössner S
    J Hypertens Suppl; 1985 Dec; 3(4):S69-71. PubMed ID: 3913756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum lipid levels in hypertensive patients during captopril treatment.
    Nishide T; Shirai K; Shinomiya M; Ishikawa Y; Murano S; Morisaki N; Saito Y; Yoshida S; Sasaki N
    Clin Ther; 1989; 11(6):820-7. PubMed ID: 2692824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive properties of tiapamil (RO 11-1781)--a new calcium antagonist--in patients with mild and moderate essential hypertension.
    Velasco M; Morillo J; Urbina A; Kögler P; Leishman B; Pasquier M; Hernändez-Pieretti O
    Int J Clin Pharmacol Res; 1987; 7(6):443-54. PubMed ID: 3440635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained-release nicardipine in mild-to-moderate hypertension.
    Fagan TC; Tyler ED; Reitman MA; Kenley S; Weber MA
    Chest; 1993 Aug; 104(2):427-33. PubMed ID: 8339631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of lipid metabolism during antihypertensive treatment with nicardipine sr.
    Pasanisi F; Marotta T; Ferrara LA; Russo O; Mancini M
    Eur J Clin Pharmacol; 1992; 43(3):225-7. PubMed ID: 1425884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of the pharmacodynamics and pharmacokinetics of nicardipine combined with enalapril in essential hypertension.
    Donnelly R; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):723-7. PubMed ID: 2450244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
    Maclean D; Mitchell ET; Laing EM; Macdonald FC; Gough KJ; Dow RJ; McDevitt DG
    Br J Clin Pharmacol; 1989 May; 27(5):569-80. PubMed ID: 2667597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of slow-release nicardipine on ambulatory and clinic blood pressure in mild hypertension.
    Cox JP; Ryan J; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1989 Jul; 28(1):79-82. PubMed ID: 2673316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicardipine sustained release in hypertension.
    Webster J; Petrie JC; Jeffers TA; Roy-Chaudhury P; Crichton W; Witte K; Jamieson M; MacDonald FC; Beard M; Dow RJ
    Br J Clin Pharmacol; 1991 Oct; 32(4):433-9. PubMed ID: 1958436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
    Naukkarinen VA; Karppinen K; Sarna S
    Eur J Clin Pharmacol; 1987; 33(2):119-26. PubMed ID: 3319640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous nicardipine for the treatment of severe hypertension.
    Wallin JD; Cook ME; Blanski L; Bienvenu GS; Clifton GG; Langford H; Turlapaty P; Laddu A
    Am J Med; 1988 Sep; 85(3):331-8. PubMed ID: 3414728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicardipine monotherapy in ambulatory elderly patients with hypertension.
    Krakoff LR
    Am Heart J; 1989 Jan; 117(1):250-5. PubMed ID: 2643284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
    Danielsson A; Bjerle P; Ek B; Steen L; Suhr O
    Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a long acting formulation of nicardipine in hypertension by clinic and home recorded blood pressures and Doppler aortovelography.
    Webster J; Witte K; Rawles J; Petrie JC; Jeffers TA
    Br J Clin Pharmacol; 1989 May; 27(5):563-8. PubMed ID: 2757880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the long-term efficacy and tolerability of oral nicardipine in hypertensive patients.
    Taylor SH; Frais MA; Lee P; Verma SP; Jackson N; Reynolds G; Silke B
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):139S-142S. PubMed ID: 3940158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.